The Ebola outbreak emerging in the eastern Democratic Republic of Congo is causing concern in international health circles due to the dense population in the region and the rapid spread of the outbreak. The World Health Organization declared the outbreak a public health emergency in mid-May. Approximately 1,000 cases and hundreds of deaths have been recorded due to the Bundibugyo virus type. While global health teams are making intense efforts to control the outbreak, the US administration's decision to send Americans exposed to the virus to a quarantine facility in Kenya, where there are no Ebola cases, sparked controversy. A Kenyan court temporarily halted this plan. US officials announced that if more American Ebola patients emerge, their treatments will be carried out in Europe. The Ebola virus is not transmitted through respiratory routes but spreads easily through blood, saliva, and other body fluids. The virus affects blood vessels, damaging vital organs. Early symptoms include fever, headache, sore throat, fatigue, and muscle pain. There is no approved vaccine or treatment yet for the Bundibugyo virus, but work continues on two potential vaccine candidates. This type of virus is thought to be carried by African fruit bats. Due to the speed of the outbreak's spread and conflicts in the region, there is a risk of it spreading to other areas.